INSUBCONTINENT EXCLUSIVE:
Trialjectory, which is developing a new technology service to match cancer patients with clinical trials, has raised $2.7 million to finance
Trialjectory chief executive and co-founder
availability of more treatment options overall
Additionally, it is a very complex process to match the right patient with the right treatment, especially with the rise of personalized
Its software then groups that information into clusters and standardizes the information to create a database that highlights patient
attributes that would be appropriate for clinical trials.Patients are then matched to the clinical trials after filling out a
platform continue to grow quickly
We believe that the company has the potential to become a go-to resource for the global medical community to help doctors provide
